ECO Animal Health Group plc

LSE EAH.L

ECO Animal Health Group plc EBIT Margin for the year ending March 31, 2024: 4.12%

ECO Animal Health Group plc EBIT Margin is 4.12% for the year ending March 31, 2024, a -30.45% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

ECO Animal Health Group plc EBIT Margin for the year ending March 31, 2023 was 5.93%, a 198.80% change year over year.
ECO Animal Health Group plc EBIT Margin for the year ending March 31, 2022 was 1.98%, a -87.61% change year over year.
ECO Animal Health Group plc EBIT Margin for the year ending March 31, 2021 was 16.00%, a 77.40% change year over year.
ECO Animal Health Group plc EBIT Margin for the year ending March 31, 2020 was 9.02%, a -40.49% change year over year.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

LSE: EAH.L

ECO Animal Health Group plc

CEO	Mr. David Charles Hallas
IPO Date	Sept. 26, 1995
Location	United Kingdom
Headquarters	78 Coombe Road
Employees	227
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Drugstores & Retail Pharmacies Meat Personal Care Pet Food Vaccines

Description

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is headquartered in New Malden, the United Kingdom.

Key trends

Past 5 years